Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
3.210
-0.090 (-2.73%)
Oct 26, 2026, 3:13 PM EDT - Market open
Camp4 Therapeutics Market Cap
Camp4 Therapeutics has a market cap or net worth of $201.44 million as of October 26, 2026. It is the 20,442nd most valuable company in the world and the 3,540th biggest in the United States. Its market cap has increased by 15.60% in one year.
Market Cap
201.44M
Enterprise Value
117.41M
1-Year Change
15.60%
Global Rank
Country Rank
#3,540 United States
Category
ChartMarket Cap Chart
Since the IPO on October 11, 2024, Camp4 Therapeutics's market cap has decreased from $208.55M to $201.44M, a decrease of -3.41%. That is a compound annual growth rate of -1.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 201.44M | -36.66% |
| Dec 31, 2025 | 318.03M | 202.65% |
| Dec 31, 2024 | 105.08M | -49.61% |
| Oct 11, 2024 | 208.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 230.10M |
| InflaRx | 229.89M |
| Lexeo Therapeutics | 229.72M |
| Sol-Gel Technologies | 227.38M |
| Keros Therapeutics | 223.65M |
| BridgeBio Oncology Therapeutics | 213.26M |
| Zentalis Pharmaceuticals | 209.22M |
| Protalix BioTherapeutics | 205.46M |